Small animal models of heart failure: development of novel therapies, past and present.
about
Relevance of the Carotid Body Chemoreflex in the Progression of Heart FailureCardiovascular imaging: what have we learned from animal models?Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment CriteriaModel-specific selection of molecular targets for heart failure gene therapyGene delivery technologies for cardiac applicationsRole of estrogen in diastolic dysfunctionDPP4 deficiency preserved cardiac function in abdominal aortic banding ratsAccelerated dual-contrast first-pass perfusion MRI of the mouse heart: development and application to diet-induced obese miceMyocardial fibrosis: biomedical research from bench to bedside.Ultrasound-induced heart rate decrease: role of the vagus nerve.New approaches in small animal echocardiography: imaging the sounds of silence.Long-term left ventricular remodelling in rat model of nonreperfused myocardial infarction: sequential MR imaging using a 3T clinical scanner.Chronic Endurance Exercise Impairs Cardiac Structure and Function in Middle-Aged Mice with Impaired Nrf2 Signaling.SWI/SNF chromatin remodeling enzymes are associated with cardiac hypertrophy in a genetic rat model of hypertensionT-tubule remodelling disturbs localized β2-adrenergic signalling in rat ventricular myocytes during the progression of heart failure.The calcium release-activated calcium channel Orai1 represents a crucial component in hypertrophic compensation and the development of dilated cardiomyopathy.The Structure-function remodeling in rabbit hearts of myocardial infarctionGenetic lineage tracing defines myofibroblast origin and function in the injured heart.Response of various conduit arteries in tachycardia- and volume overload-induced heart failure.Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy.Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension.Effect of transverse aortic constriction on cardiac structure, function and gene expression in pregnant rats.Permanent ligation of the left anterior descending coronary artery in mice: a model of post-myocardial infarction remodelling and heart failureA new model of congestive heart failure in rats.Genetics of common forms of heart failure: challenges and potential solutions.Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload.Survival, exercise capacity, and left ventricular remodeling in a rat model of chronic mitral regurgitation: serial echocardiography and pressure-volume analysisMice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophyNovel mouse model of left ventricular pressure overload and infarction causing predictable ventricular remodelling and progression to heart failure.A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II.Variable phenotype in murine transverse aortic constriction.Shear-Thinning Supramolecular Hydrogels with Secondary Autonomous Covalent Crosslinking to Modulate Viscoelastic Properties In Vivo.Prognostic Value of Troponin I for Infarct Size to Improve Preclinical Myocardial Infarction Small Animal ModelsSex differences in porcine left ventricular myocardial remodeling due to right ventricular pacing.Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure.A novel rat model of heart failure induced by high methionine diet showing evidence of association between hyperhomocysteinemia and activation of NF-kappaB.Pathophysiological model of chronic heart failure complicated with renal failure caused by three-quarter nephrectomy and subcutaneous injection of isoprenaline.Models for preclinical studies in aging-related disorders: One is not for all.Protective Effects of Sheng-Mai-San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice.Hierarchical approaches for systems modeling in cardiac development.
P2860
Q26771307-42801173-DF69-462F-927C-5948A8598C3AQ26779676-E2A92AB7-EB43-4719-949E-C14E398A7294Q26797153-41A6E5ED-2E15-4C40-9A20-44EA0846EB1BQ26823061-EA6979B5-757B-411A-912C-2E6EBB71C31EQ26863362-EBDAA5E3-379E-48FC-AFA6-2D5B17F74222Q27026798-590E1950-DC5A-47C0-97DD-79C22A479B6AQ28538591-4F5BD144-E3DB-4D2B-B146-A95BB2971116Q30360543-EBA0DBBD-06C6-430F-8B21-0191D964B0A4Q30362840-04437A9B-71A8-4B57-8A19-468E157ABF4EQ30392226-7A1DE204-2DF7-40B9-88C1-7AD77F39B96AQ30461404-A4787B37-7648-428D-BBDC-BDBB7DB8401FQ30525833-430BBF68-765C-4A8B-94B1-E418F67996E7Q33627707-D3095BA6-8485-4DA0-B8EE-B9C842488B58Q33694215-79563D3A-F89E-4309-A02E-9D95B87D9F9EQ33705761-B110DF74-7611-4655-AFA9-DD49B7EDC388Q33721878-32F979B8-F9E9-4927-94F1-DC910E6D3C9AQ33856650-EA32A812-F886-4E32-B879-B4C3B5BEB6F4Q33908363-D956358C-7275-4961-8B66-578037AF7985Q34050582-BA0BBADF-9799-43BC-914E-334BF4D2DCB4Q34512883-CBAD641B-63B0-4E21-BC42-88DF629FD449Q34633337-679E4482-C6E3-41C3-ADB2-16CA039B089CQ35107617-71690D73-D612-4ECA-B2C6-1D83CC270A90Q35161660-532401B5-6C8F-45E0-95F5-A64DF7719B42Q35315333-707D2B8D-1E31-4EE3-873F-277893040C58Q35525031-30CAE24E-A9D1-4A66-B604-EDD79246A96FQ35534909-DE3384C8-8C93-4A35-A1B4-B7693BEF5776Q35566714-342D7118-C9A9-4D9F-99B8-1352064A68A7Q35577699-3CA8F03E-B7ED-4720-8980-80B97DCCD509Q35916146-5E846C20-B787-4F30-A7F9-14FA5525B1B4Q36114343-6FC43DFA-B0B0-4C17-89F7-160A09B58133Q36141950-56422600-F6A9-4B6C-B510-7658A8760C76Q36219544-83401DA0-1FE4-47DC-88B4-E05EC943BD4EQ36323087-50E626F8-AA2D-49B0-A53D-955421171114Q36364241-514FF5F0-0F89-46F6-A298-5E30314B50A5Q36407107-3A0DB256-19BE-471F-870B-309B4DAABB63Q36595109-FFE6F302-2C1D-4A64-A36F-F4B73F14EC8DQ36603487-166415F1-FD59-43CE-BEAA-0D1F78342D3FQ36738466-B1F5F6BA-A1B9-4D81-B66F-B8B44DE45A98Q36747612-24F66DB7-0C6C-4DA3-B211-2359706FD1C5Q36763260-3A76FFB1-D7CF-4D80-B916-B77AEF0403CC
P2860
Small animal models of heart failure: development of novel therapies, past and present.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Small animal models of heart failure: development of novel therapies, past and present.
@en
Small animal models of heart failure: development of novel therapies, past and present.
@nl
type
label
Small animal models of heart failure: development of novel therapies, past and present.
@en
Small animal models of heart failure: development of novel therapies, past and present.
@nl
prefLabel
Small animal models of heart failure: development of novel therapies, past and present.
@en
Small animal models of heart failure: development of novel therapies, past and present.
@nl
P1476
Small animal models of heart failure: development of novel therapies, past and present.
@en
P2093
Monica R Hall-Porter
Richard D Patten
P304
P356
10.1161/CIRCHEARTFAILURE.108.839761
P577
2009-03-01T00:00:00Z